Variable | CVC access (n = 182) | PD or fistula access (n = 167) | P |
---|---|---|---|
Age at dialysis start, years, (mean ± SD) | 62 ± 16.0 | 62 ± 16 | 0.95 |
Male gender, n (%) | 96 (53) | 106 (63) | 0.05 |
Caucasian race, n (%) | 166 (91) | 157 (94) | 0.42 |
Dialysis Access, n (%) | |||
CVC | 56 (98) | 182 (52) | <0.001 |
AVF | 1 (2) | 95 (27) | <0.001 |
PD catheter | 0 | 72 (21) | <0.001 |
Cause of ESRD, n (%) | |||
Diabetes | 64 (35) | 46 (28) | 0.14 |
Polycystic kidney disease | 9 (5) | 21 (13) | 0.01 |
Glomerulonephritis | 23 (13) | 22 (13) | 1.00 |
Referral time before dialysis start, days, (median, IQR) | 734, 196 to 1966 | 1623, 687 to 3115 | <0.001 |
Referral < 3 months, n (%) | 32 (18) | 2 (1) | <0.001 |
Comorbidity | |||
CCI (median, IQR) | 5, 3 to 7 | 3, 2 to 6 | <0.001 |
Diabetes, n (%) | 91 (50) | 63 (38) | 0.02 |
Coronary artery disease, n (%) | 62 (34) | 38 (23) | 0.02 |
Congestive heart failure, n (%) | 44 (24) | 33 (20) | 0.37 |
Peripheral vascular disease n (%) | 54 (30) | 24 (14) | 0.001 |
Malignancya, n (%) | 23 (13) | 11 (7) | 0.07 |
Laboratory Values | |||
Hemoglobin, g/L, (mean ± SD) | 96 ± 17 | 105 ± 17 | <0.001 |
Albumin, g/L, (median, IQR) | 31, 25 to 34 | 34, 31 to 38 | <0.001 |
Phosphate, mmol/L, (median, IQR) | 1.8, 1.5 to 2.3 | 1.8, 1.5 to 2.2 | 0.19 |
Imputed phosphateb | 1.9, 1.6 to 2.3 | 1.8, 1.5 to 2.1 | 0.13 |
eGFR, ml/min/1.73 m2, (median, IQR) | 7.2, 5.8 to 9.7 | 8.1, 6.2 to 10.9 | 0.01 |
Imputed eGFRc | 7.3, 5.8 to 9.6 | 8.1, 6.2 to 10.9 | 0.01 |